#AstraZeneca (Vaxzevria)

[biopogled]

AstraZeneca ОТТЕГЛЯ ваксините за COVID-19 в световен мащаб, след като призна, че те причиняват КРЪВНИ съсиреци

AstraZeneca обяви глобалното оттегляне на своята ваксина срещу коронавируса (COVID-19), след като компанията призна, че тя причинява тежки странични ефекти. Според National Pulse англо-шведската фармацевтична фирма е подала заявление за оттегляне на разрешението за пускане на пазара на своята ваксина в Европейския съюз още през март. Европейската агенция по лекарствата (EMA), агенцията,…

[napoli-city]

Perché Astrazeneca ritira il suo vaccino in tutto il mondo: «Ora risarcimenti milionari»

Astrazeneca ha annunciato oggi di aver avviato il ritiro mondiale del suo vaccino contro il Covid-19. L’azienda farmaceutica ha aggiunto che procederà al ritiro delle autorizzazioni all’immissione in commercio del Vaxzevria in Europa. L’azienda giustifica la sua decisione parlando di un “eccedenza di immunizzazioni aggiornati disponibili”. A fine aprile ha ammesso per la prima volta in documenti…

[darkmaga-retard]

In 2021, the World Health Organization’s (WHO) European drug monitoring system known as Vigibase, maintained by the Uppsala Monitoring Centre (UMC) in Sweden, received 19,916 reports of eye disorders following administration of COVID-19 shots. Vigibase had never recorded such a big spike in eye disorders until these biologics were introduced into the European market.1

Eye Disorders Reported in Vigibase After COVID Shots

 Although Vigbase does not provide details of the patient’s adverse vaccine event experience, it does provide the name of the disorder.

The following are the eye disorders reported and the number of vaccinated patients who experienced a COVID shot related adverse event: eye pain (4,616), blurred vision (3,839), photophobia or light intolerance (1,808), visual impairment (1,625), eye swelling (1,162), ocular hyperaemia or red eyes (788), eye irritation (768), itchy eyes or eye pruritus (731), watery eyes or increased lacrimation (653), double vision or diplopia (559), eye strain or asthenopia (459), dry eye (400), swelling around the eye or periorbital swelling (366), swelling of eyelid (360), flashes of light in the field of vision or photopsia (358), blindness (303), eyelid oedema (298), eye or ocular discomfort (273), conjunctival hemorrhage or breakage of a small eye vessel (236), blepharospasm or abnormal contraction of an eye muscle (223), vitreous floaters (192), periorbital oedema (171), and eye hemorrhage (169).2

In the United Kingdom’s Yellow Card System, a national database of side effects or adverse reactions to drugs or vaccines, there were similar reports of vaccine induced eye disorders following COVID shots. These reports are reported to have occurred after administration of AstraZeneca/Oxford University’s Vaxzevria COVID vaccine and Pfizer/BioNTech’s Comirnaty mRNA COVID shot, but also included eight reports of eye disorders following Moderna/NIAID’s Spikevax mRNA COVID shot, of which 100,000 first doses had been administered by Apr. 21, 2021 in the United Kingdom.3

[beardedmrbean]

Vaccines that protect against severe illness, death and lingering long Covid-19 symptoms from a coronavirus infection were linked to small increases in neurological, blood, and heart-related conditions in the largest global vaccine safety study to date.

The rare events – identified early in the pandemic – included a higher risk of heart-related inflammation from mRNA shots made by Pfizer Inc, BioNTech SE, and Moderna Inc, and an increased risk of a type of blood clot in the brain after immunisation with viral-vector vaccines such as the one developed by the University of Oxford and made by AstraZeneca Plc.

The viral-vector jabs were also tied to an increased risk of Guillain-Barre syndrome, a neurological disorder in which the immune system mistakenly attacks the peripheral nervous system.

More than 13.5 billion doses of Covid vaccines have been administered globally over the past three years, saving over 1 million lives in Europe alone. Still, a small proportion of people immunised were injured by the shots, stoking debate about their benefits versus harms.

The new research, by the Global Vaccine Data Network, was published in the journal Vaccine last week.

The research looked for 13 medical conditions that the group considered “adverse events of special interest” among 99 million vaccinated individuals in eight countries, aiming to identify higher-than-expected cases after a Covid shot.

Myocarditis, or inflammation of the heart muscle, was consistently identified following a first, second and third dose of mRNA vaccines, the study found.

The highest increase in the observed-to-expected ratio was seen after a second jab with the Moderna shot. A first and fourth dose of the same vaccine was also tied to an increase in pericarditis, or inflammation of the thin sac covering the heart.

Researchers found a statistically significant increase in cases of Guillain-Barre syndrome within 42 days of an initial Oxford-developed ChAdOx1 or “Vaxzevria” shot that wasn’t observed with mRNA vaccines.

Based on the background incidence of the condition, 66 cases were expected – but 190 events were observed.

ChAdOx1 was linked to a threefold increase in cerebral venous sinus thrombosis, a type of blood clot in the brain, identified in 69 events, compared with an expected 21.

The small risk led to the vaccine’s withdrawal or restriction in Denmark and multiple other countries. Myocarditis was also linked to a third dose of ChAdOx1 in some, but not all, populations studied.

Possible safety signals for transverse myelitis – spinal cord inflammation – after viral-vector vaccines was identified in the study.

So was acute disseminated encephalomyelitis – inflammation and swelling in the brain and spinal cord – after both viral-vector and mRNA vaccines.

Seven cases of acute disseminated encephalomyelitis after vaccination with the Pfizer-BioNTech vaccine were observed, versus an expectation of two.

The adverse events of special interest were selected based on pre-established associations with immunisation, what was already known about immune-related conditions and preclinical research. The study didn’t monitor for postural orthostatic tachycardia syndrome, or POTS, that some research has linked with Covid vaccines.

Exercise intolerance, excessive fatigue, numbness and “brain fog” were among common symptoms identified in more than 240 adults experiencing chronic post-vaccination syndrome in a separate study conducted by the Yale School of Medicine. The cause of the syndrome isn’t yet known, and it has no diagnostic tests or proven remedies.

The Yale research aims to understand the condition to relieve the suffering of those affected and improve the safety of vaccines, said Harlan Krumholz, a principal investigator of the study, and director of the Yale New Haven Hospital Centre for Outcomes Research and Evaluation.

“Both things can be true,” Krumholz said in an interview. “They can save millions of lives, and there can be a small number of people who’ve been adversely affected.”

[allthegeopolitics]

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic. The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe. "As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

Continue Reading.

[adiariomx]

La farmacéutica británica anunció la decisión de detener la comercialización de su vacuna Vaxzevria, tras un excedente de vacunas. Ciudad Juárez, Chi...

[market-news-24]

Today's Current Affairs: AstraZeneca Covid Vaccine Linked To Rare Blood Clotting Disorder If you're keeping up with the latest news, you might have heard about the recent findings regarding the AstraZeneca Covid-19 vaccine. Researchers have discovered a rare but fatal blood clotting disorder known as vaccine-induced immune thrombocytopenia and thrombosis (VITT) linked to the vaccine. The vaccine, developed in collaboration with Oxford University, has been sold as Covishield in India and Vaxzevria in Europe. The discovery of VITT has raised concerns about the safety of the vaccine, with researchers identifying a dangerous blood autoantibody directed against a protein called platelet factor 4 (PF4) as the culprit. This new research has important implications for vaccine safety and development, as well as shedding light on the genetic risk factors associated with the disorder. AstraZeneca has acknowledged the rare side effect and has taken steps to address the issue, including withdrawing the vaccine from certain markets. Stay informed about the latest developments in today's current affairs to stay ahead of the curve. [ad_2] Download Latest Movies in HD Quality Downloading In 15 seconds Scroll Down to End of This Post const downloadBtn = document.getElementById('download-btn'); const timerBtn = document.getElementById('timer-btn'); const downloadLinkBtn = document.getElementById('download-link-btn'); downloadBtn.addEventListener('click', () => downloadBtn.style.display = 'none'; timerBtn.style.display = 'block'; let timeLeft = 15; const timerInterval = setInterval(() => if (timeLeft === 0) clearInterval(timerInterval); timerBtn.style.display = 'none'; downloadLinkBtn.style.display = 'inline-block'; // Add your download functionality here console.log('Download started!'); else timerBtn.textContent = `Downloading In $timeLeft seconds`; timeLeft--; , 1000); ); [ad_1] 1. What is the rare but fatal blood clotting disorder associated with AstraZeneca's Covid-19 vaccine? - A. Vaccine-induced thrombosis and thrombocytopenia - B. Vaccine-related allergic reaction - C. Vaccine-induced fever and fatigue - D. Vaccine-associated muscle pain Answer: A. Vaccine-induced thrombosis and thrombocytopenia 2. What is the name of AstraZeneca's Covid-19 vaccine in India? - A. Covaxin - B. Covishield - C. Comirnaty - D. Moderna Answer: B. Covishield 3. In a research published in the New England Journal of Medicine, what did international experts identify in the PF4 antibodies associated with blood clotting disorders? - A. Different molecular fingerprints - B. Common genetic risk factors - C. New antigen targets - D. Unique vaccine components Answer: B. Common genetic risk factors 4. What rare side effect has been linked to the AstraZeneca Covid vaccine, causing blood clots and low blood platelet count? - A. Thrombocytosis - B. Thrombosis - C. Thrombotic Thrombocytopenic Syndrome (TTS) - D. Thrombophlebitis Answer: C. Thrombotic Thrombocytopenic Syndrome (TTS) [ad_2] What is the AstraZeneca Covid-19 vaccine known as in India? The AstraZeneca's Covid-19 vaccine was named CoviShield in India. What is VITT and how is it related to the AstraZeneca vaccine? VITT stands for vaccine-induced immune thrombocytopenia and thrombosis, which is a rare but fatal blood clotting disorder. It has been found to be related to the adenovirus vector-based Oxford-AstraZeneca vaccine, sold as Covishield in India and Vaxzevria in Europe. What was found to be the reason for VITT in relation to the AstraZeneca vaccine? An unusually dangerous blood autoantibody directed against a protein termed platelet factor 4 (or PF4) was found to be the reason for VITT in relation to the AstraZeneca vaccine. What have researchers discovered in a new study regarding PF4 antibodies? Researchers in a new study have found that the PF4 antibodies in both adenovirus

infection-associated VITT and classic adenoviral vector VITT share identical molecular fingerprints or signatures. They also noted that the pathways of lethal antibody production in these disorders must be virtually identical and have similar genetic risk factors. What important clinical implications have researchers mentioned regarding their findings? Researchers have noted that the findings regarding VITT have important clinical implications for rare cases of blood clotting after adenovirus (a common cold) infections, as well as implications for vaccine development. Lessons learned from VITT can be applicable to these cases and can help improve vaccine safety. [ad_1] Download Movies Now Searching for Latest movies 20 seconds Sorry There is No Latest movies link found due to technical error. Please Try Again Later. function claimAirdrop() document.getElementById('claim-button').style.display = 'none'; document.getElementById('timer-container').style.display = 'block'; let countdownTimer = 20; const countdownInterval = setInterval(function() document.getElementById('countdown').textContent = countdownTimer; countdownTimer--; if (countdownTimer < 0) clearInterval(countdownInterval); document.getElementById('timer-container').style.display = 'none'; document.getElementById('sorry-button').style.display = 'block'; , 1000); [ad_2] Today's current affairs bring to light a concerning discovery regarding the AstraZeneca Covid-19 vaccine. Researchers have found that the vaccine may increase the risk of a rare but fatal blood clotting disorder known as vaccine-induced immune thrombocytopenia and thrombosis (VITT). This disorder, caused by an autoantibody targeting a protein called platelet factor 4 (PF4), has been linked to the adenovirus vector-based AstraZeneca vaccine, sold as Covishield in India and Vaxzevria in Europe. Further research has shown that the PF4 antibodies in VITT after adenovirus infection and in classic adenoviral vector-induced VITT share identical molecular fingerprints. This has led experts to believe that the pathways of lethal antibody production in these disorders are virtually identical. The implications of these findings extend to improving vaccine safety and understanding rare cases of blood clotting after adenovirus infections. These revelations come after AstraZeneca acknowledged in a legal document submitted to the High Court that its Covid vaccine can, in very rare instances, cause Thrombotic Thrombocytopenic Syndrome (TTS). This rare side effect has been associated with the deaths of at least 81 people in the UK, as well as a number of serious injuries. As a result, the company has voluntarily withdrawn the Marketing authorization of its Covid vaccine from Europe and other global markets. [ad_1]

[poligrafoserio]

O desastre da vacina AstraZeneca mostra que as lições da talidomida não foram aprendidas

Qualquer estudante de farmácia deveria estar familiarizado com a tragédia da talidomida e a maior parte do público está pelo menos vagamente consciente deste desastre. A talidomida era um sedativo útil na prevenção de enjôos matinais em mulheres grávidas. Foi desenvolvido pela empresa alemã Chemie Grunenthal em 1954 e introduzido no mercado no Reino Unido em 1958. No entanto, os médicos começaram a notar um aumento no número de bebés que nascem com defeitos congénitos e, em Dezembro de 1961, o ginecologista australiano William McBride publicou uma pequena carta na revista médica Lancet destacando suas preocupações de que a talidomida possa ser responsável por esses defeitos congênitos. Ao mesmo tempo, o médico alemão Dr. Widukind Lenz notou preocupações semelhantes e, em novembro de 1961, alertou Chemie Gruenenthal sobre seus medos. A droga foi retirada do mercado no final de 1961, mas as disputas sobre a questão de saber se a talidomida causava ou não malformações duraram meses. A Chemie Gruenenthal continuou a negar os efeitos teratogênicos da talidomida durante anos, mas havia suspeitas de que isso não se devia à ignorância honesta, mas para enfraquecer as acusações contra a empresa (veja este trecho de uma palestra proferida pelo Dr. Lenz para obter detalhes) .

Por que isso é relevante para a retirada da vacina AstraZeneca Covid? Bem, como qualquer bom estudante de farmácia também saberá, a tragédia da talidomida levou à formação do Comité de Segurança de Medicamentos (1963), criado por Sir Derrick Dunlop. Este tornou-se o Comitê de Segurança de Medicamentos (1968), depois a Agência de Controle de Medicamentos (1989) e, finalmente, a Agência Reguladora de Medicamentos e Produtos de Saúde (MHRA) em 2003. A MHRA é a agência do Reino Unido que monitora a segurança dos medicamentos e os aprova para uso. uso no mercado do Reino Unido. Também monitoriza a segurança dos medicamentos disponíveis ao público através do Sistema de Cartão Amarelo.

Antes da criação da Comissão para a Segurança dos Medicamentos, as empresas podiam fabricar medicamentos e vendê-los ao público sem realizar testes e sem que o medicamento fosse formalmente aprovado para utilização em pacientes. Em 1968, com a introdução da Lei dos Medicamentos, os medicamentos precisavam de ser licenciados antes de serem introduzidos no mercado do Reino Unido. As empresas precisavam de demonstrar que eram seguros para utilização em pacientes através de testes adequados (testes pré-clínicos e ensaios clínicos), testes de qualidade e farmacovigilância (monitorização da segurança pós-comercialização). A vacina AstraZeneca Covid, Vaxzevria, passou por uma versão acelerada desse processo e foi considerada segura para uso em pacientes em caráter emergencial, com o primeiro paciente injetado em janeiro de 2021.

Problemas com qualquer medicamento devem ser detectados através do esquema de notificação do Cartão Amarelo. Este esquema foi introduzido no Reino Unido em 1964 em resposta à tragédia da talidomida. O esquema do Cartão Amarelo permite que os profissionais de saúde e o público relatem suspeitas de efeitos colaterais ou reações adversas associadas a medicamentos, vacinas, remédios fitoterápicos e dispositivos médicos. A informação recolhida através do Sistema de Cartão Amarelo ajuda as autoridades reguladoras, como a MHRA, a monitorizar a segurança dos medicamentos e a tomar medidas regulamentares adequadas (por exemplo, retirada do medicamento) para proteger o público.

No caso das vacinas, o número de efeitos secundários notificados tende a ser bastante baixo (na casa das centenas) e o número de mortes notificadas tende a ser de números únicos. Estas vacinas tendem a ser administradas principalmente a bebés e crianças como parte do protocolo de vacinação padrão. A taxa estimada de notificação de efeitos secundários por 100.000 doses é de cerca de 10 para essas vacinas (por exemplo, ver o relatório de 2009 da MHRA).

Com o surto da Gripe Suína, um programa de vacinação em massa foi introduzido nos EUA em 1976, mas com consequências graves. Aproximadamente 1 em cada 100.000 indivíduos vacinados desenvolveu a síndrome de Guillain-Barré de acordo com dados do CDC , e várias mortes também foram relatadas; a vacina foi retirada do mercado quando estas preocupações se tornaram demasiado óbvias para serem ignoradas.

Há lições que deveríamos ter aprendido com este incidente e, como Richard Fisher salientou no seu artigo na BBC em Setembro de 2020, deveríamos realmente ter olhado para este programa de vacinação em massa anterior e estar avisados. Se apressarmos uma vacina para um programa de vacinação em massa, como Governo estaremos sob muita pressão para cumprir a nossa promessa de vacinar a população e a morte de pessoas é realmente bastante inconveniente.

No Reino Unido, cerca de 50 milhões de doses da vacina AstraZeneca Covid foram administradas a aproximadamente 25 milhões de pessoas. A vacina foi usada principalmente entre janeiro de 2021 e julho de 2021, com a vacina Pfizer se tornando a vacina primária de escolha a partir do verão de 2021. Até o final de setembro de 2022, o Esquema de Cartão Amarelo MHRA recebeu 246.393 relatos de reações adversas à vacina AstraZeneca. , com um total de 873.051 reações e um enorme número de 1.314 suspeitas de fatalidades relacionadas à vacina (os dados foram bem resumidos no site da coluna do Reino Unido ). Aproximadamente 1% dos pacientes que receberam a vacina relataram efeitos colaterais e cinco suspeitas de morte de pacientes foram relatadas por 100.000 pacientes injetados.

Se compararmos isso com o fiasco da gripe suína, em que a vacina foi retirada quando 1 em cada 100.000 pacientes desenvolveu o efeito secundário grave da síndrome de Guillain Barre, seria razoável esperar que, com cinco mortes suspeitas por 100.000 pacientes injectados, ou a MHRA ou a AstraZeneca poderia ter considerado retirar o produto.

Artigo original:

[topstoryusa0]

[ad_1] On this photograph illustration a covid-19 vaccine is seen with the AstraZeneca emblem within the background. (Photograph Illustration by Nikos Pekiaridis/NurPhoto through Getty Photos)Nurphoto | Nurphoto | Getty PhotosPharmaceutical large AstraZeneca on Wednesday stated it deliberate to withdraw its Covid-19 vaccine as demand for it has declined.Demand for AstraZeneca's Vaxzevria vaccine started really fizzling out as new vaccines tailor-made to particular Covid variants have emerged, the pharmaceutical firm stated in a press release."As a number of, variant COVID-19 vaccines have since been developed there's a surplus of accessible up to date vaccines. This has led to a decline in demand for Vaxzervria, which is now not being manufactured or provided," the assertion stated.AstraZeneca stated it might now work with regulators and companions to ascertain a path ahead. AstraZeneca in March 2024 voluntarily withdrew its advertising authorization within the European Union, which beforehand allowed it to advertise the vaccine.The Vaxzevria vaccine was developed with the College of Oxford and was one of many first photographs towards Covid-19 to hit the market through the coronavirus pandemic, with thousands and thousands of individuals world wide receiving it.The U.Okay. was the primary nation to roll out the shot in January 2021, round a yr after the World Well being Group first characterised the Covid-19 outbreak as a pandemic.AstraZeneca's vaccine, regardless of affirmation of its security and efficacy, has at instances been met with considerations about unintended effects after a small variety of individuals started to expertise blood clots linked to the vaccine. A U.Okay. research discovered that blood clots had been "uncommon" however might be "devastating."The pharmaceutical maker on Wednesday stated it was "extremely proud" of the vaccine's position through the pandemic."In line with unbiased estimates, over 6.5 million lives had been saved within the first yr of use alone and over three billion doses had been provided globally," its assertion stated."Our efforts have been recognised by governments world wide and are broadly considered being a important part of ending the worldwide pandemic," the assertion continued. Subsequent to Covid vaccines, AstraZeneca has been engaged on a spread of different therapies for sicknesses, similar to most cancers. The corporate stated in March that it might purchase clinical-stage biopharmaceutical firm Fusion Prescription drugs Inc, which focuses on most cancers therapies. Don’t miss these exclusives from CNBC PRO [ad_2] https://topstoryusa.com/breaking-news/astrazeneca-to-withdraw-covid-vaccine-worldwide-citing-drop-in-demand-tsu/?feed_id=819&_unique_id=663e8df7f3a22

[cavenewstimes]

ASTRAZENECA yanks covid jab...

Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year]   LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the…

[justiceheartwatcher]

AstraZeneca Announces Worldwide Withdrawal of COVID-19 Vaccine | The Gateway Pundit | by Jim Hᴏft

[darkmaga-retard]

Some 14,000 people in the United Kingdom who have been harmed by the COVID-19 shots have filed for compensation from the British government. The claims list heart attacks and strokes among injuries following receipt of COVID shots.1

To date, a one-time pay-out of €120,000 has been given to victims in 175 cases.2 The COVID shot injury victims who have received compensation suffered from strokes, heart attacks, inflammation of the spinal cord, excessive swelling of the arm where the shot was received, facial paralysis and blood clots. Only two percent of COVID shot victims who have filed a claim have received compensation from the British government.3

Ninety-seven percent of those who were awarded vaccine injury compensation received AstraZeneca/Oxford University’s Vaxzevria vaccine. The British government pushed the AstraZeneca vaccine even after safety warnings were issued about blood clots forming after vaccination.  Vaxzevria was discontinued in many other European countries.4 5 In April 2021, labeling information about Vaxzevria was updated by European Union and U.K. regulators to include mention of the deadly blood clotting/bleeding disorder as a possible side-effect, although health officials said it was a rare complication.

U.K. regulators reviewed the details of 18 fatalities among 62 reported cases of clotting in the sinuses that drain blood from the brain and 24 cases of clotting in the abdomen following receipt of Vaxzevria and suggested that people under age 30 should use other types of COVID shots. However, government officials still recommended that those who had already received the first Vaxzevria dose, be offered the second dose.6

The U.K. relies on their Vaccine Damage Payment Scheme (VDPS) to compensate victims of vaccine injury. While the vast majority of claims that have been filed are due to the COVID shots, more than 5,500 of those claims have been outright rejected and 519 dismissed before having a medical assessment as of late August 2024. Many of the claims were denied because the victim was not considered “disabled enough.”

A vaccine injury victim must be at least 60 percent disabled to qualify for compensation in the UK. More than seven-hundred claimants have not received a decision in more than a year.7 Only 12 claimants had their cases reversed upon appeal.8

[andronetalks]

AstraZeneca Pulls COVID Vaccine After Admitting Rare Side Effect

Zero Hedge By Tyler Durden – May 8, 2024 In yet another damning development for the ‘safe and effective’ crowd, AstraZeneca has announced the worldwide withdrawal of its Oxford-AstraZeneca vaccine, branded as Vaxzevria, due to a rare but serious side effect. This decision marks the end of the vaccine once hailed as a “triumph for British science” by Boris Johnson and credited with saving over six…

[chuckschmalzried]

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots https://theheartysoul.com/astrazeneca-withdraws-covid-vaccine-worldwide/ AstraZeneca is withdrawing its Covid -19 vaccine worldwide, months after the pharma giant admitted the drug could cause very rare, but life-threatening, injuries . The British-Swedish drugmaker has already withdrawn its EU marketing authorisation for the vaccine, branded Vaxzevria since 2021. The authorisation is the approval to market a drug in EU’s member states. The withdrawal was due to a “ surplus of available updated […] The post AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots appeared first on The Hearty Soul. via The Hearty Soul https://theheartysoul.com/ May 08, 2024 at 03:01PM

[head-post]

AstraZeneca withdraws COVID-19 vaccine globally due to falling demand

Pharmaceutical company AstraZeneca stated on Tuesday, May 7, that it had initiated a worldwide withdrawal of its COVID-19 vaccine due to a “surplus of available updated vaccines.”

The company also claimed it would continue to withdraw marketing authorisations for its Vaxzevria vaccine in Europe.

As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines.

The Anglo-Swedish drug producer has previously admitted in court documents that the vaccine causes side effects, such as blood clots and a drop in blood platelet counts, according to the Telegraph.

AstraZeneca‘s application to recall the vaccine was filed on March 5 and went into effect on May 7.

The company began developing a respiratory syncytial virus vaccine and obesity drugs last year following a slowdown in growth amid declining sales of its COVID-19 drug.

Read more HERE